Vertex has been playing hardball. They came to an agreement with Scotland last September and England in October, but other agreements are coming slowly. It is a

Vertex has been playing hardball. They came to an agreement with Scotland last September and England in October, but other agreements are coming slowly. It is a real hardship for patients following Trikafta on Twitter and reading every day about gaining 30 points of lung function after only a few weeks, but not having the treatment available. CF patients may have close to a normal lifespan with Trikafta, assuming that progress is made on treating some common infections, such as a pseudomonas aeruginosa. That means a lot of patients getting a very expensive drug for a very long time.